Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

42.57
Delayed Data
As of Sep 20
 -0.80 / -1.84%
Today’s Change
37.44
Today|||52-Week Range
90.98
-2.09%
Year-to-Date

Today’s Trading

Previous close43.37
Today’s open43.20
Day’s range42.17 - 44.60
Volume1,607,829
Average volume (3 months)485,287
Market cap$2.5B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+44.24%
Earnings growth (this year)-67.45%
Earnings growth (next 5 years)-84.49%
Revenue growth (last year)+1,871.48%
P/E ratioNM
Price/Sales42.03
Price/Book3.56

Competitors

 Today’s
change
Today’s
% change
BHVNBiohaven Pharmaceuti...-0.81-1.70%
FOLDAmicus Therapeutics ...-0.17-1.77%
PTCTPTC Therapeutics Inc-0.03-0.08%
ARNAArena Pharmaceutical...-0.12-0.23%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$1.63
Annual revenue (last year)$51.5M
Annual profit (last year)-$197.6M
Net profit margin-383.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
Chief Operating Officer
Wladimir Hogenhuis
Corporate headquarters
Novato, California

Forecasts